Stem Cell Transplantation

1. Cyclophosphamide, etoposide and carboplatine plus non-cryopreserved autologous peripheral blood stem cell transplantation rescue for patients with refractory or relapsed non-Hodgkin's lymphomas.

Author
Mabed M; Al-Kgodary T;
Institution
Hematology and Medical Oncology Unit, Faculty of Medicine, Mansoura University, Mansoura, Egypt. mohmabed@mans.edu.eg
Journal
Bone Marrow Transplant. 2006 Apr;37(8):739-43.
Abstract URL
Click here to view abstract

2. Autologous hematopoietic stem cell transplantation for older patients with relapsed non-Hodgkin's lymphoma.

Author
Buadi FK; Micallef IN; Ansell SM; Porrata LF; Dispenzieri A; Elliot MA; Gastineau DA; Gertz MA; Lacy MQ; Litzow MR; Tefferi A; Inwards DJ; Buadi FK; Micallef IN; Ansell SM; Porrata LF; Dispenzieri A; Elliot MA; Gastineau DA; Gertz MA; Lacy MQ; Litzow MR; Tefferi A; Inwards DJ;
Institution
Division of Hematology, Department of Internal Medicine, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA.
Journal
Bone Marrow Transplant. 2006 Jun;37(11):1017-22.
Abstract URL
Click here to view abstract

3. Improved outcomes in intermediate- and high-risk aggressive non-Hodgkin lymphoma after autologous hematopoietic stem cell transplantation substituting intravenous for oral busulfan in a busulfan, cyclophosphamide, and etoposide preparative regimen.

Author
Aggarwal C; Gupta S; Vaughan WP; Saylors GB; Salzman DE; Katz RO; Nance AG; Tilden AB; Carabasi MH; Aggarwal C; Gupta S; Vaughan WP; Saylors GB; Salzman DE; Katz RO; Nance AG; Tilden AB; Carabasi MH;
Institution
Department of Internal Medicine, School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY, USA.
Journal
Biol Blood Marrow Transplant. 2006 Jul;12(7):770-7.
Abstract URL
Click here to view abstract

4. High-dose carmustine, etoposide, and cyclophosphamide followed by allogeneic hematopoietic cell transplantation for non-Hodgkin lymphoma.

Author
Law LY; Horning SJ; Wong RM; Johnston LJ; Laport GG; Lowsky R; Shizuru JA; Blume KG; Negrin RS; Stockerl-Goldstein KE; Law LY; Horning SJ; Wong RM; Johnston LJ; Laport GG; Lowsky R; Shizuru JA; Blume KG; Negrin RS; Stockerl-Goldstein KE;
Institution
Division of Blood and Marrow Transplantation, Stanford University Medical Center, Stanford, California 94305, USA.
Journal
Biol Blood Marrow Transplant. 2006 Jul;12(7):703-11.
Abstract URL
Click here to view abstract

5. Comparison of reduced-intensity and conventional myeloablative regimens for allogeneic transplantation in non-Hodgkin's lymphoma.

Author
Rodriguez R; Nademanee A; Ruel N; Smith E; Krishnan A; Popplewell L; Zain J; Patane K; Kogut N; Nakamura R; Sarkodee-Adoo C; Forman SJ;
Institution
Hematology and Hematopoietic Cell Transplantation, City of Hope Comprehensive Cancer Center, Duarte, California 91001, USA. robertorodgriguez@coh.org
Journal
Biol Blood Marrow Transplant. 2006 Dec;12(12):1326-34.
Abstract URL
Click here to view abstract

6. High response rate to donor lymphocyte infusion after allogeneic stem cell transplantation for indolent non-Hodgkin lymphoma.

Author
Bloor AJ; Thomson K; Chowdhry N; Verfuerth S; Ings SJ; Chakraverty R; Linch DC; Goldstone AH; Peggs KS; Mackinnon S;
Institution
Department of Haematology, Royal Free and University College London School of Medicine, London, United Kingdom. drbloor@tiscali.co.uk
Journal
Biol Blood Marrow Transplant. 2008 Jan;14(1):50-8.
Abstract URL
Click here to view abstract

7. Early lymphocyte recovery following autologous peripheral stem cell transplantation is associated with better survival in younger patients with lymphoproliferative disorders.

Author
Boulassel MR; Herr AL; deB Edwardes MD; Galal A; Lachance S; Laneuville P; Routy JP;
Institution
Division of Hematology, McGill University Health Centre, Royal Victoria Hospital, Montreal, Que., H3A 1A1 Canada.
Journal
Hematology. 2006 Jun;11(3):165-70.
Abstract URL
Click here to view abstract

8. Diabetes and risk of non-Hodgkin lymphoma: a case-control study.

Author
Scotti L; Tavani A; Bosetti C; Maso LD; Talamini R; Montella M; Franceschi S; La Vecchia C;
Institution
Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.
Journal
Tumori. 2007 Jan-Feb;93(1):1-3.
Abstract URL
Click here to view abstract

9. Obesity in survivors of childhood acute lymphoblastic leukemia and lymphoma.

Author
Razzouk BI; Rose SR; Hongeng S; Wallace D; Smeltzer MP; Zacher M; Pui CH; Hudson MM;
Institution
Department of Hematology-Oncology, St Jude Children's Research Hospital and the University of Tennessee Health Science Center, Memphis, TN 38105-2794, USA. bassem.razzouk@stjude.org
Journal
J Clin Oncol. 2007 Apr 1;25(10):1183-9.
Abstract URL
Click here to view abstract

10. High-dose chemotherapy with autologous stem cell support in first-line treatment of aggressive non-Hodgkin lymphoma - results of a comprehensive meta-analysis.

Author
Greb A; Bohlius J; Trelle S; Schiefer D; De Souza CA; Gisselbrecht C; Intragumtornchai T; Kaiser U; Kluin-Nelemans HC; Martelli M; Milpied NJ; Santini G; Verdonck LF; Vitolo U; Schwarzer G; Engert A; Greb A; Bohlius J; Trelle S; Schiefer D; De Souza CA; Gisselbrecht C; Intragumtornchai T; Kaiser U; Kluin-Nelemans HC; Martelli M; Milpied NJ; Santini G; Verdonck LF; Vitolo U; Schwarzer G; Engert A;
Institution
Department of Internal Medicine I, University of Cologne, Cologne, Germany.
Journal
Cancer Treat Rev. 2007 Jun;33(4):338-46. Epub 2007 Apr 2.
Abstract URL
Click here to view abstract